Methods and compositions for treating B-cell malignancies | Patent Number 11872220

US 11872220 B2
Application Number17882695
Publication NumberUS 20230074759 A1
Pendency1 year, 5 months, 11 days
Filled DateAug 8, 2022
Priority DateAug 9, 2021
Publication DateMar 9, 2023
Expiration DateAug 8, 2041
Inventor/ApplicantsAndrew STEELE
Ulrike Philippar
Eric Frederik Eldering
Karoline Kielbassa
Andrew Steele
A.P. KATER
A. P. Kater
Marco Vincent Haselager
Marco Vincent HASELAGER
Ulrike PHILIPPAR
Eric Frederik ELDERING
Karoline KIELBASSA
ExaminesVALENROD, YEVGENY
Art Unit1628
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.